Energy Efficiency and Renewable Energy System Technology Research and Development (SBIR [R43/R44])
The summary for the Energy Efficiency and Renewable Energy System Technology Research and Development (SBIR [R43/R44]) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Energy Efficiency and Renewable Energy System Technology Research and Development (SBIR [R43/R44]): Purpose. On December 19, 2007, President George W. Bush signed into law the Energy Independence and Security Act of 2007 (Act), P.L. 110-140. This Act requires SBIR/STTR agencies, whenever possible and appropriate, to give high priority within the SBIR and STTR programs to energy efficiency or renewable energy system research and development projects (R&D). As part of the implementation of this Act, this Funding Opportunity Announcement (FOA) encourages eligible United States small business concerns (SBCs) whose biomedical research is related to energy efficiency or renewable energy systems, to submit SBIR Phase I, Phase II, and Fast-Track grant applications for R&D projects in those areas. Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, Fast-Track, and Phase II Competing Renewal applications (NIH only), and runs in parallel with an FOA of identical scientific scope, PA-09-101, that solicits applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received.
| Federal Grant Title: | Energy Efficiency and Renewable Energy System Technology Research and Development (SBIR [R43/R44]) |
| Federal Agency Name: | National Institutes of Health |
| Grant Categories: | Education Health |
| Type of Opportunity: | Discretionary |
| Funding Opportunity Number: | PA-09-100 |
| Type of Funding: | Grant |
| CFDA Numbers: | 93.121 |
| CFDA Descriptions: | Oral Diseases and Disorders Research |
| Current Application Deadline: | Jan 07, 2012 |
| Original Application Deadline: | Jan 07, 2012 |
| Posted Date: | Feb 12, 2009 |
| Creation Date: | Feb 12, 2009 |
| Archive Date: | Feb 07, 2012 |
| Total Program Funding: | |
| Maximum Federal Grant Award: | |
| Minimum Federal Grant Award: | |
| Expected Number of Awards: | |
| Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Small businesses
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]] - Similar Government Grants
- • Systems Biology of Infection and Inflammation in Chronic Diseases (U19 Clinical Trial Not ...
- • NextTech: Translational Development of Next-Generation Diagnostic and Therapeutic Devices ...
- • NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, an...
- • Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) (P30...
- • Collaborative Program Grant for Interdisciplinary Teams (RM1 Clinical Trial Optional)
- • Epidemiological and Behavioral Research in Oral Health
- • Metagenomic Analyses of the Oral Microbiome
- • Phase Iii Clinical Trials in Oral Infectious Diseases
- More Grants from the National Institutes of Health
- • Systems Biology of Infection and Inflammation in Chronic Diseases (U19 Clinical Trial Not ...
- • NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)
- • Genomic and Biologic Therapies for ADRD (U01 Clinical Trial Optional)
- • Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical ...
- • The NIDDK Disorders of Gastrointestinal Interoception Consortium (DGIC) - Clinical Researc...
